Next Article in Journal
Pivotal Role of Inflammation in Celiac Disease
Next Article in Special Issue
“Soft Protein Corona” as the Stabilizer of the Methionine-Coated Silver Nanoparticles in the Physiological Environment: Insights into the Mechanism of the Interaction
Previous Article in Journal
A Set of Dysregulated Target Genes to Reduce Neuroinflammation at Molecular Level
Previous Article in Special Issue
Starch-Coated Magnetic Iron Oxide Nanoparticles for Affinity Purification of Recombinant Proteins
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 13
10.3390/ijms23137179
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nanoparticles Influence Lytic Phage T4-like Performance In Vitro

by
Xymena Stachurska
1,*,
Krzysztof Cendrowski
2,
Kamila Pachnowska
3,4,
Agnieszka Piegat
5,
Ewa Mijowska
4 and
Paweł Nawrotek
1
1
Department of Microbiology and Biotechnology, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology in Szczecin, Piastów Avenue 45, 70-311 Szczecin, Poland
2
Faculty of Civil and Environmental Engineering, West Pomeranian University of Technology in Szczecin, Piastów Avenue 50a, 70-311 Szczecin, Poland
3
Department of Horticulture, Faculty of Environmental Management and Agriculture, West Pomeranian University of Technology in Szczecin, Juliusza Słowackiego 17, 71-434 Szczecin, Poland
4
Department of Nanomaterials Physicochemistry, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin, Piastów Avenue 45, 70-311 Szczecin, Poland
5
Department of Polymer and Biomaterials Science, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin, Piastów Avenue 42, 71-065 Szczecin, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(13), 7179; https://doi.org/10.3390/ijms23137179
Submission received: 22 May 2022 / Revised: 25 June 2022 / Accepted: 26 June 2022 / Published: 28 June 2022
(This article belongs to the Special Issue Interactions of Nanoparticles with Biomolecules)
Browse Figures
Versions Notes

Abstract

:
Little is known about interactions of non-filamentous, complex-structured lytic phages and free, non-ordered nanoparticles. Emerging questions about their possible bio-sanitization co-applications or predictions of possible contact effects in the environment require testing. Therefore, we revealed the influence of various nanoparticles (NPs; SiO2, TiO2-SiO2, TiO2, Fe3O4, Fe3O4-SiO2 and SiO2-Fe3O4-TiO2) on a T4-like phage. In great detail, we investigated phage plaque-forming ability, phage lytic performance, phage progeny burst times and titers by the eclipse phase determinations. Additionally, it was proved that TEM micrographs and results of NP zeta potentials (ZP) were crucial to explain the obtained microbiological data. We propose that the mere presence of the nanoparticle charge is not sufficient for the phage to attach specifically to the NPs, consequently influencing the phage performance. The zeta potential values in the NPs are of the greatest influence. The threshold values were established at ZP < −35 (mV) for phage tail binding, and ZP > 35 (mV) for phage head binding. When NPs do not meet these requirements, phage–nanoparticle physical interaction becomes nonspecific. We also showed that NPs altered the phage lytic activity, regardless of the used NP concentration. Most of the tested nanoparticles positively influenced the phage lytic performance, except for SiO2 and Fe3O4-SiO2, with a ZP lower than −35 (mV), binding with the phage infective part—the tail.

Graphical Abstract

1. Introduction

Bacteriophages (phages), viruses specific to bacterial cells, are a powerful tool for building a variety of self-organizing nanostructures that can be used in the diagnosis and treatment of many diseases [1]. Interest in phages grew rapidly in the face of the ineffectiveness of routinely used therapeutic methods, although their use has not yet been widely adopted by modern medicine, with the exception of Georgia, Russia and Poland, where therapeutic phages have been used for a long time [2]. They show a significant antibacterial potential and, as passable bacteriolytic units, they are used in the mono-phage or multi-phage (phage cocktails) therapy of bacterial diseases, including those caused by multi-drug-resistant strains [2,3,4]. Phages represent the most numerous (approx. 1031) and probably the oldest, the most genetically diverse and the fastest replicating (approx. 1023 infections/s. on the Earth scale) biological form [5,6]. The biochemical complexity of the molecules that make up the phage virion and its varied size, expressed on the nanometric scale, mean that bacteriophages can be treated as natural nanoparticles made of molecules with different charge and hydrophobicity, which can also interact with other materials, including nanomaterials [7,8,9].
Nanomaterials, in turn, are structures produced at the nano scale, at least one dimension of which ranges from 1 to 100 nm, and thanks to the favorable ratio of surface area to their volume, they can be more biologically active than macroparticles with the same chemical composition [10,11,12,13,14]. The sizes of nanomaterials, similar to subcellular elements, allow them to penetrate through natural barriers, such as biological membranes, so that, after being introduced into the body, they can reach the smallest vessels and any types of cells [10,11]. Currently, due to the large variety of nanomaterials, they are proposed for use in the diagnosis and treatment of diseases (fluorescent biological labels, drug and gene delivery, detection of pathogens and proteins, probing of DNA structure, tissue engineering, tumor destruction, separation and purification of biological molecules), manufacturing and materials, environment, electronics, energy harvesting, food and agriculture [15,16,17]. Above all, their high antimicrobial activity is emphasized, which is an alternative to the currently used methods of neutralizing pathogens [18,19].
The application potential of bacteriophages or nanomaterials is currently being intensively developed, and at the same time, attempts are being made to increase their action and significance by obtaining synergistic effects [20,21]. On the other hand, the creation of biohybrids composed of both inorganic nanoparticles and phage biomolecules, opens new potential applications in very different fields, including medicine or nanobiotechnology [22,23].
Prospectively, it is possible to develop specific strategies based on a combination of phage and nanomaterials, used not only for eradication but also for sanitization, biocontrol or bioconservation, in the case of most bacterial pathogens, including drug-resistant and biofilm-forming bacteria [24,25]. It is also desirable to have an enhanced bactericidal effect, most preferably synergy, as it is proven for some antibiotics and bacteriophages [3,26,27]. In the case of phage–antibiotic synergy (PAS), it was shown that antibiotic and phage resistance have a small probability of emergence at the same time and bacteria resistant to one agent will be susceptible to the other agent [28]. Moreover, selective pressure of bacteriophage promotes phage-resistant mutations in bacteria, although with a weakening of their fitness. Such fitness trade-offs include reduced virulence, resensitization to antibiotics and colonization defects [29,30,31,32,33]. Therefore, similar effects can be expected in the context of the simultaneous use of lytic bacteriophages and nanoparticles.
With the current state of the art, the topic of phage–nanoparticle interactions mostly focuses on designing novel, functional materials and composites, mainly bioactive surfaces and biotemplate designs [34]. However, not much is known about the contact effects of non-filamentous lytic phages (especially those of complex head–tail structure) and non-ordered nanoparticles, with particular emphasis on their interactions. For that reason, in this work, we assessed the potential in lytic phage T4-like and nanoparticle co-application, primarily with a focus on the potential influence of nanoparticles on phage lytic activity.

2. Materials and Methods

2.1. Bacterial Host and Bacteriophage

Lytic bacteriophage T45 was used, as a model for T4-like phages. Escherichia coli K-12 C600 [35] was used as a host strain for the phage propagation [3]. Bacterium and phage were part of a collection from the Department of Microbiology and Biotechnology at the West Pomeranian University of Technology, Szczecin. Bacterium revival and phage propagation were conducted as described previously [3]. Briefly, after storing in the Microbank™ system at −20 °C, the bacterium was revived on Luria-Bertani (LB agar) (BioMaxima, Lublin, Poland) plates and incubated at 37 °C for 24 h. Afterwards, 50 mL of LB broth was inoculated with a single colony of E. coli, and incubated at 37 °C with shaking (160 rpm) in an orbital rotating shaker (Shaker-Incubator ES-20, BioSan, Józefów, Poland) to reach OD600nm = 0.5 (exponential phase of growth and a titer of approx. 2 × 108 CFU). Optical density values were measured using an Infinite 200 PRO NanoQuant microplate reader (Tecan, Männedorf, Switzerland). Afterwards, bacteriophage was added and samples were further incubated until the lysis occurred. For lysate purification, chloroform was added (10%, v/v) and samples were vortexed for 5 min, and then centrifuged (Eppendorf Centrifuge model 5810 R, Hamburg, Germany) at 5000 rpm for 15 min at 4 °C. The supernatant was stored at 4 °C for further use. Phage activity and titer was tested by a double-overlay agar plaque assay [36].

2.2. Chemical Reagents

Titanium dioxide particles were obtained from the AEROXIDE® TiO2 P 25 (Evonik, Essen, Germany). The Fe3O4 particles used as a core for the nanostructures and as reference samples were purchased from Sigma Aldrich (637106) and were used as received. The nanomagnetite structure size was 50–100 nm (purity 97%, according to information provided by the supplier). Titanium (IV) butoxide (TBT) and hexadecyl (trimethyl)azanium bromide (CTAB) were purchased from Sigma Aldrich (MERCK, Darmstadt, Germany). Ethanol, propanol and 30% hydrochloric acid ammonia solution were bought from Chempur (Piekary Slaskie, Poland).

2.3. Nanoparticle Synthesis

2.3.1. Synthesis of Silica Shell on Iron Oxide Nanoparticles (SiO2-Fe3O4) and Their Functionalization with Titanium Dioxide (SiO2-Fe3O4-TiO2)

In order to create a mesoporous shell on the surface of iron oxide particles (Fe3O4-SiO2), 2 g of Fe3O4 and 0.930 g of hexadecyl (trimethyl)azanium bromide (CTAB) were dispersed in 200 mL of ethanol (EtOH) mixed together with 300 mL of water and 2.5 mL of ammonia solution (NH3 × H2O). The dispersion of the iron oxide particles in ethanol–water solution was obtained by simultaneous stirring and sonication. Further, 1.5 mL of tetraethyl orthosilicate (TEOS) was added and kept stirring for 18 h at room temperature. The obtained particles were separated with a magnet and dried in air. In the last step, the nanostructures were annealed at 500 °C for 2 h to remove CTAB blocking the pores. The silica shell synthesis was reported previously [37].
Iron oxide particles with mesoporous silica shell (Fe3O4-SiO2) were functionalized with titanium dioxide according to previously described method [38,39]. Fe3O4-SiO2 structures after annealing were added to the concentrated TBT in order to fill pores with TiO2. The mixture of Fe3O4-SiO2 and TBT was then sonicated for 2 h in an ultrasonic washer at 50 °C. Then Fe3O4-SiO2 structures were separated from the concentrated TBT using magnet and washed with isopropanol. After washing with isopropanol, nanostructures were washed with ethanol to hydrolyze remaining TBT and dried in air at 60 °C. The dried material was heated in an inert atmosphere for 2 h at 400 °C.

2.3.2. Synthesis of Silica Nanospheres (SiO2) and Functionalization with Titanium Dioxide

Mesoporous silica nanospheres were prepared according to the previously reported Stöber method [39,40]. Briefly, synthesis of mesoporous silica nanospheres was performed by mixing 50 mL ethanol (EtOH) and 2.5 mL of ammonia solution (NH3 × H2O) together in a glass-bottomed flask. Ethanol and ammonium solution were stirred using magnetic stirrer. After mixing them together, 1.5 mL of tetraethyl orthosilicate (TEOS) was added to the flask and stirred for 24 h at room temperature. The obtained silica particles were obtained by evaporation solvents.
In the next step, to create a mesoporous external layer on the as-produced silica core particles (SiO2), mixture of 200 mg of silica spheres, 160 mg CTAB; 0.48 mL NH3 × H2O; 100 mL EtOH; and 120 mL H2O was prepared [40]. In order to homogeneously disperse the solution, obtained mixture was simultaneously stirred and sonicated. After obtaining a homogeneous suspension, 0.28 mL TEOS was added and the mixture was stirred for a further 24 h. The suspension was then evaporated and obtained product was annealed in air at 500 °C for 2 h.
The modification of mesoporous channels in silica nanospheres with titanium dioxide (TiO2-SiO2) was made according to the previous procedure [38,39]. As such, 100 mg of silica core–shell structures was added to the 3 mL of concentrated TBT. Then, the suspension was sonicated for 3 h in anhydrous conditions at 50 °C. The suspension was then diluted with propanol and centrifuged to separate the excess of titanium dioxide precursor. In order to remove the excess of TBT, the sample was washed several times with propanol. After the purification step, the nanostructures filled with TBT were treated with ethanol to hydrolyze the precursor to the titanium dioxide. Finally, the sample was evaporated and heated in an air flow at 400 °C for 2 h to transform the titanium dioxide into its anatase phase.

2.4. Nanoparticle Microscopic Analysis, Zeta Potentials and Stock Suspension Preparation

Visualization of nanomaterials was performed using a transmission electron microscope (TEM; Tecnai G2 F20 S-TWIN; FEI, Hillsboro, OR, USA) equipped with a high-angle, annular, dark-field HAADF detector (STEM) and with energy-dispersive X-ray spectroscopy (EDS). In order to characterize the crystal structure of the samples, X-ray powder diffractometer (XRD, Aeris, Malvern Panalytical) with Cu-Kα radiation (λ = 1.544 Å) and an accelerating voltage of 40 kV was used.
For zeta potential analysis Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) with a 633 nm red laser was used. All water-based dispersions of nanoparticles were sonicated for 30 min, directly before measurements in ultrasonic bath. For the analysis, the nanoparticle sample of the desired concentration (5 mg/mL) was flushed through a folded capillary cell and the measurement was carried out if there were no visible air bubble inclusions present. The cell was placed into the Zetasizer and equilibrated at 20 °C (close to the average temperature in the laboratory) for 2 min, of which there were three replications.
For stock suspension preparation, nanoparticles were placed in the glass tubes and sterile deionized water was added to reach a concentration of 10 mg/100 µL in each tube. Samples were thoroughly vortexed for 10 min and then sonified in the ultrasonic cleaner (2 × 30 min) by submerging the tubes to ensure particle dispersion.

2.5. Coincubation Assay for Plaque-Forming Ability Determination

In order to test phage T45 plaque-forming ability in the presence of nanoparticles, coincubation assay was carried out. Briefly, 1980 µL of TM buffer (50 mM Tris-HCl, 10 mM MgSO4 at pH 7.5) and 20 µL of phage lysate (1.2 × 1014 PFU/mL) were added into wells of 12-well flat-bottom polystyrene plates. Then, nanoparticles were added to reach final concentrations of 0.5, 0.1 and 0.05 mg/mL. TM buffer with phage lysate and nanoparticle-free deionized water was used as a control. Samples were incubated at room temperature (22 °C) and 160 rpm in an orbital rotating shaker. Then, samples were collected immediately and after every 12 h, centrifuged at 5000 rpm for 2 min at 4 °C, and the supernatant was spotted on the double-layer agar plates. The experiment was conducted in triplicate.

2.6. Bacteriophage Lysis of Liquid Culture

For the host culture lysis studies in the presence of nanoparticles, 100 µL of an overnight culture of bacteria was refreshed in 2 mL of LB medium (BioMaxima, Lublin, Poland) in 12-well flat-bottom polystyrene plates and allowed to grow at 37 °C with shaking (160 rpm) until reaching OD600nm = 0.2. Then each culture was infected with the phage at MOI (multiplicity of infection) = 0.1 and nanoparticles were added to reach final concentrations of 0.5, 0.1 and 0.05 mg/mL. The OD600nm measurements of the samples were made every 30 min by collecting 100 µL of the sample supernatant into the 96-well flat-bottom polystyrene plates, in order to avoid false measurements caused by nanoparticles. LB medium was used as the blank sample, bacterial culture with phage-free buffer and nanoparticle-free deionized water was used as E. coli growth control and bacterial culture with phage lysate and nanoparticle-free deionized water was used as lysis control. The experiment was technically repeated three times, conducted in triplicate.

2.7. Determination of Phage Eclipse Period

In order to assess the time between phage infection and the appearance of phage progeny within the cell (intracellular phage/total phage) in the presence of nanoparticles, phage eclipse periods were estimated. As such, 10 mL of LB medium was inoculated with 100 µL of an overnight culture of E. coli. The culture was grown until OD600nm = 0.5 and then centrifuged (3500 rpm for 5 min at 4 °C) and the pellet was suspended in 5 mL of fresh LB medium. At this point, the culture was infected with the phage at MOI = 0.01 and incubated with shaking (160 rpm) at 37 °C for 2 min. Then, 100 μL of infected cells was transferred to 5 mL of fresh LB broth in 12-well flat-bottom polystyrene plates and nanoparticles were added to reach final concentrations of 0.5, 0.1 and 0.05 mg/mL (time 0) and incubated at 37 °C with shaking (160 rpm). Samples were collected every 2 min, treated with chloroform (10%, v/v), vortexed for 1 min and then centrifuged at 5000 rpm for 5 min. The number of PFU per mL was estimated by titration using the double-layer agar plate method. The experiment was conducted in triplicate.

2.8. Microscopic Visualization of Phage–Nanoparticle Interactions

For phage purification, polyethylene glycol (PEG) 8000 (Pol-Aura, Dywity, Poland) with NaCl (Pol-Aura, Dywity, Poland) (final concentration 10% w/v PEG, 0.5 M NaCl) was added to the phage lysate and mixed thoroughly by inversion. The mixture was stored overnight at 4 °C, to allow the phage particles to form a precipitate. The precipitate was collected by centrifugation at 5000 rpm for 1.5 h at 4 °C. Supernatant was carefully discarded and the pellet was gently suspended in the TM buffer and left overnight at 4 °C. Then, PEG8000 was removed and phage particles were extracted by adding an equal volume of chloroform to the sample, vortexing for 20 min and centrifugating at 5000 rpm for 15 min at 4 °C. The upper phase containing phages was further purified by filtrating with a 0.22 µm PES filter. For phage morphology determination, phage particles were deposited on formvar/carbon-coated copper grids (400 mesh) and stained with UranyLess stain solution (Delta Microscopies, Mauressac, France) (the protocol available on http://uranyless.com, accessed on 1 October 2020). For phage–nanoparticle interaction visualization, purified phage T45 was mixed with the highest nanoparticle concentrations (0.5 mg/mL), prior to deposition on grids and staining.

2.9. Statistical Analysis

One-way ANOVA was used to statistically analyze the results, along with Dunnett’s multiple comparisons test. Differences were considered significant at p ≤ 0.05. All statistical analyses were carried out using GraphPad Prism 8.01 (GraphPad Software, San Diego, CA, USA). All data are presented as mean with standard deviation (SD).

3. Results

3.1. Nanomaterials Characterization

TEM images of commercial titanium dioxide particles are presented in Figure 1A,A’. Titanium dioxide particles have a spherical-like shape with size in a range between 20 and 50 nm. According to information provided by the supplier, P25 has a surface area between 35 and 65 m2/g and chemical composition of anatase and rutile.
Detailed information on the iron oxide and iron oxide particles with silica shell is published in our previous work [37]. TEM images of the Fe3O4 and Fe3O4-SiO2 morphology show cube-like structures in a hexagonal shape, with particle size in a range of 50–100 nm for Fe3O4 (Figure 1D,D’) and 60–120 nm for Fe3O4-SiO2 (Figure 1E,E’). The Fe3O4 is composed from the magnetite phase, as are the Fe3O4-SiO2 particles [37].
The synthesized SiO2-Fe3O4-TiO2 is presented in Figure 1F,F’. SiO2-Fe3O4-TiO2 particles have similar shape and structure to SiO2-Fe3O4 particles, with solid, cubic core (from dense material) and mesoporous silica shell. The mesoporous silica shell of SiO2-Fe3O4-TiO2 is filled with titanium dioxide. On the surface of the silica shell of the SiO2-Fe3O4-TiO2, there are noticeable darker agglomerates of titanium dioxide. The XRD analysis presented in the Supplementary Material (Supplementary Material, Figure S1) proves that the structures are composed of iron oxide and titanium dioxide.
Detailed information on the SiO2 and TiO2-SiO2 chemical, physical and photocatalytic properties is presented in our previous publications [38,39]. Our work showed that the nanomaterials are characterized by high purity and high surface area. According to the TEM images, the synthesized materials have a spherical shape and are built from a solid core, with a mesoporous shell of SiO2 (Figure 1B,B’). TEM images presented in Figure 1C,C’ show that the mesoporous channels were filled with titanium dioxide. Additionally, titanium dioxide agglomerates (darker particles) can be noticed on the surface of the silica nanospheres. EDS mapping proved that the titanium dioxide is in the external mesoporous silica layer of TiO2-SiO2. The obtained materials are composed of silica, oxygen and titanium elements [40,41]. Titanium dioxide in mesopores is mostly in the anatase phase [41]. The synthesized photocatalyst shows high catalytic performance in the degradation of dyes [41], other organic pollutants [40] and shows antibacterial activity [42].
The Zeta potential analysis is presented in Table 1. From all of the studied materials, the highest maximal and minimal zeta potential charges had titanium dioxide (positive charge of 36 mV) and silica particles (negative charge −51 mV). The core–shell structure of silica and titanium dioxide TiO2-SiO2 also shows negative charge at −25 mV. The third important material used in the presented studies was iron oxide particles. These particles showed a slightly negative zeta potential charge of −1.1 mV. Due to the combination of iron oxide cores and silica shell, Fe3O4-SiO2 showed a highly negative charge at −37 mV. As presented in Table 1, titanium dioxide has the highest positive charge, but in combination with highly negative silica and almost passive iron oxide charge, the SiO2-Fe3O4-TiO2 particles showed negative charge at −19 mV.

3.2. Coincubation Assay

The results of this experiment are shown in Figure 2. Phage T45’s ability to form plaques after incubation with different nanoparticles was determined with comparison to the control (without the addition of nanoparticles). “Full ability” was assessed when spot-plaque morphology was the same as in the control spot-plaque (complete clearance of the bacterial lawn in the location of the spot); “partial ability” when in spot-plaque location, small, single phage plaques were observed; “ability visibly reduced” when in spot-plaque location, visible reduction of the small, single phage plaques was observed; “no plaques” when in spot-plaque location, no single phage plaques were observed. Detailed visualization of the results plate can be found in the Supplementary Material (Figure S2).
The most noticeable differences in the ability of the phage to form plaques occurred at time 0—immediately after adding the nanoparticles to the phage suspension (Figure 2). The highest concentration of nanoparticles (0.5 mg/mL) resulted in pronounced changes (“partial ability” or “ability visibly reduced”) in plaque visibility for most samples, but for titanium dioxide (TiO2), the lowest concentration (0.05 mg/mL) resulted in the most notable changes in the plaque-forming ability of the bacteriophage (“ability visibly reduced”). For samples with SiO2 nanoparticles, changes in the visibility of plaques were maintained throughout the incubation period (60 h), with the most abundant changes (“ability visibly reduced”) at 48 and 60 h of incubation, but only at the highest concentration of the nanoparticles (0.5 mg/mL). Changes were also recorded at 60 h of incubation, at a concentration of 0.1 mg/mL. In samples with TiO2-SiO2 nanoparticles, the reduction in plaque-forming ability was only observed at 36, 48 and 60 h of incubation at the highest nanoparticle concentration, and similarly to SiO2, at 60 h of incubation, at the concentration of 0.1 mg/mL (Figure 2).

3.3. Bacteriophage Lytic Performance

For the lysis ability test, bacteriophage T45 performance against E. coli was tested in the presence of selected nanoparticles at different concentrations (0.5, 0.1 and 0.05 mg/mL), by the changes in optical density measures. Phage lytic performance was assessed by the analysis of areas under the lysis curves at 180, 210 and 240 min of incubation, when differences were most pronounced (Figure 3).
The quickest and most significant changes in phage lytic activity were observed at the highest (0.5 mg/mL) concentration of nanoparticles, and the highest percentage values occurred at 240 min of incubation. Compared to the lysis control, the presence of TiO2 resulted in increased lytic performance by 24%, 50% and 64% at 180, 210 and 240 min, respectively. Similarly, TiO2-SiO2 presence resulted in improved lytic performance by 10%, 37% and 63% at 180, 210 and 240 min, respectively. A significant improvement in T45 lysis ability was also noted when Fe3O4 was added, but only at 210 and 240 min after phage infection, by 28%. Comparable results were observed for SiO2-Fe3O4-TiO2, where in the presence of the nanoparticles, phage lytic performance increased by 27% and 45% at 210 and 240 min, respectively. At a concentration of 0.5 mg/mL, reductions in phage lytic activity were also noted. This was the case with Fe3O4-SiO2 nanoparticles (decreased by 11%, 18%, 17% at 180, 210, 240 min, respectively) and SiO2 nanoparticles (decreased by 21% and 16% at 210 and 240 min, respectively).
At 0.1 mg/mL and 0.05 mg/mL, the greatest changes in percentage values occurred also at 240 min of incubation, but significant changes in reductive values were also detected earlier, at 180 and 210 min, whereas additive effects were present mostly at 210 and 240 min. At a concentration of 0.1 mg/mL, a significant improvement in T45 lysis ability was noted for Fe3O4, which increased phage performance by 18%, 16% and 47% at 180, 210 and 240 min, respectively. Significant lysis improvement was also detected for TiO2 (43%), TiO2-SiO2 (40%) and SiO2-Fe3O4-TiO2 (34%) at 240 min after phage infection. Reductions in phage lytic activity were recorded for Fe3O4-SiO2 and SiO2, and were similar to those at 0.5 mg/mL (Fe3O4-SiO2: decreased by 17%, 25%, 28% at 180, 210, 240 min, respectively; SiO2: decreased by 14%, 29%, 15% at 180, 210, 240 min, respectively).
The reductions at a concentration of 0.05 mg/mL were also detected for the same nanoparticles and similar to those mentioned before (Fe3O4-SiO2: decreased by 15%, 29%, 31% at 180, 210, 240 min, respectively; SiO2: decreased by 19%, 25%, 21% at 180, 210, 240 min, respectively). A significant improvement in the phage lysis ability was detected only at 210 and 240 min of incubation. At 210 min, TiO2, TiO2-SiO2 and Fe3O4 presence resulted in the phage lytic boost by 8%, 8% and 17%, respectively, and at 240 min, these values further increased to 37%, 25% and 36%, respectively. At 240 min, an improvement in phage lytic performance was also noted for SiO2-Fe3O4-TiO2 (8%) (Figure 3).

3.4. Phage Eclipse Periods after Nanoparticle Exposure

Phage T45 eclipse periods were tested in order to assess the time between infection and the appearance of phage progeny within the cell (intracellular phage/total phage) in the presence of nanoparticles. Independently to the used nanoparticle concentration, the presence of most of them resulted in a quicker and greater production of phage particle progeny from bacterial cells, compared to the control, just after 12 min of incubation (Figure 4). The highest concentration (0.5 mg/mL) of all tested nanoparticles, namely Fe3O4-SiO2, SiO2-Fe3O4-TiO2, TiO2-SiO2, SiO2, TiO2 and Fe3O4, resulted in a significant increase in phage progeny numbers of 2.79 × 107 (PFU/mL), 1.91 × 107 (PFU/mL), 2.06 × 107 (PFU/mL), 2.22 × 107 (PFU/mL), 1.59 × 107 (PFU/mL) and 1.7 × 107 (PFU/mL) after 16 min of incubation compared to the control, respectively. At a concentration of 0.1 mg/mL, the presence of SiO2-Fe3O4-TiO2, TiO2-SiO2, SiO2, TiO2 and Fe3O4 resulted in the phage progeny numbers of 1.24 × 107 (PFU/mL), 1.99 × 107 (PFU/mL), 2.84 × 107 (PFU/mL), 2.29 × 107 (PFU/mL) and 0.92 × 107 (PFU/mL) after 16 min of incubation compared to the control, respectively. That time, only Fe3O4-SiO2 presence did not alter the phage progeny numbers significantly (2.76 × 106 PFU/mL; control—1.56 × 106 PFU/mL). The lowest nanoparticle concentration (0.05 mg/mL) of Fe3O4-SiO2, SiO2-Fe3O4-TiO2, TiO2-SiO2, SiO2, TiO2 and Fe3O4 resulted in the phage progeny numbers of 3.37 × 107 (PFU/mL), 1.86 × 107 (PFU/mL), 2.06 × 107 (PFU/mL), 2.52 × 107 (PFU/mL), 2.1 × 107 (PFU/mL) and 1.94 × 107 (PFU/mL) after 16 min of incubation compared to the control, respectively (Figure 4). More detailed statistical analysis of the results of progeny phage numbers can be found in the Supplementary Material (Table S1).

3.5. Visualization of Phage–Nanoparticle Interaction

Coliphage T45 was subjected to TEM to determine phage morphology and confirm phage classification that was assumed from our previous experiments. TEM images of the phage T45 (Figure 5a,a’) resulted in classification of the virus into the Caudovirales order and the Myoviridae family, based on the typical phage morphological and infection features [43]. The images revealed that phages were in close proximity or in direct contact with nanoparticles. T45 with SiO2 showed phages bound to silica spheres by their tails (Figure 5b,b’), in line with knowledge on the charge differences based on zeta potential (Table 1). Therefore, electrostatic interaction between phage and silica nanoparticles occurred. Negatively charged silica surfaces bind with positively charged phage tails. When silica spheres were coated with titanium nanoparticles (TiO2-SiO2), nonspecific phage binding happened, irrespective of the overall negative charge in the nanoparticles (Table 1)—phage particles were attached by their negatively charged heads (Figure 5c), as well as their positively charged tails (Figure 5c’). Phage T45 in the presence of titanium dioxide attached to the positively charged TiO2 particles (Table 1) by the negatively charged head (Figure 5d,d’). When phage was in contact with Fe3O4 nanoparticles, the phage was again attached nonspecifically to the nanomaterial with close to neutral overall charge (Figure 5e,e’, Table 1). The presence of the negatively charged complex nanomaterial (SiO2-Fe3O4-TiO2) resulted in varied phage binding, with the predominance of phage flow in the direction of the nanoparticles (Figure 5f,f’). Fe3O4 nanoparticles covered by porous silica (Fe3O4-SiO2) with an overall negative charge were attached to the tail of the phage (Figure 5g). Additional images showing phage T45 and nanoparticle interactions are presented in the Supplementary Material (Figure S4).

4. Discussion

With regard to phage–nanoparticle interactions, most of the work to date has focused on designing novel, functional materials or composites. The most common approach is using phages as scaffolds, nanocomposites or templates with nanoparticle addition. These are characterized as bioinorganic nanohybrids, composed of biological macromolecules and functional inorganic nanomaterials [44]. Since nanoscale inorganic materials are challenging in assembling into defined structures, the use of self-ordered biomolecules directly obtained from nature (nucleic acids, proteins, viruses) to organize nanomaterials into predesigned patterns is proposed. Bacteriophage–gold nanoparticle hybrids using phage M13 are one example [44]. The M13 phage is also mainly used for the phage display method—the process of identifying specific biological binding blocks using phage–bacteria biology through a directed evolution process—and the phage can recognize desired materials at the molecular level due to the recognition peptides [45]. An example of the use of phage display incorporating nanoparticles is the work of You et al. [46], in which two peptides were selected from a phage display peptide library by using ferromagnetic NPs as targets, since the selected peptides were verified to display strong binding affinity to Fe3O4 NPs.
Another phage–nanoparticle combination approach is designing biosensors, which is often combined with phage display technology. Peng et al. [47] engineered phage M13 to display the receptor-binding protein that targets the desired bacteria and then thiolated the phages, which allowed the binding of gold nanoparticles that aggregated on the phages, resulting in a visible color change. Similarly, Souza et al. [48] fabricated “spontaneous, biologically active molecular networks” of filamentous phage and gold nanoparticles, working as biological sensors and cell-targeting agents, using peptide-displaying technology. With regard to designing bioactive surfaces with phages, physisorption by electrostatic forces and covalent bonding are most frequently used [34]. While covalent attachment offers a strong bond and phage detachment is not easy, it requires appropriate chemicals and rather complicated methodology [34,49]. A much simpler immobilization strategy uses the physical adsorption of the phage by electrostatic attraction between the phage and the surface [50].
However, little is known about interactions of non-filamentous lytic phages (especially of Myoviridae morphology) and free, non-ordered nanoparticles. This knowledge could be particularly useful for designing simple bio-sanitization solutions (co-application) or even prediction of phage and nanoparticle possible contact effects in the environment (potential influence of nanoparticles on phage lytic activity). Therefore, in our study, to understand the mechanisms of these phage–nanoparticle interactions, T4-like phage (T45) was used as a model. T4-like phages (similarly as bacteriophage T4) have a complex head–tail structure that is characteristic of over 95% of all known bacteriophages. The Myoviridae phage consists of more than 40 different types of structural proteins which, simplifying, form a head and a contractile tail ending in a basal plate with six tail fibers. Almost half of these proteins are exposed to the external environment, with most of them being negatively charged at a pH of ~ 7 (their isoelectric point is pI < 7), except for the fiber ends, where the pI is > 7. Positively charged fibers are electrostatically attracted by bacteria that have a negatively charged surface [51]. Nanoparticles that were chosen for this study (SiO2, TiO2-SiO2, TiO2, Fe3O4, Fe3O4-SiO2 and SiO2-Fe3O4-TiO2) were characterized with different properties (Section 3.1, Nanomaterial Characterization) to ensure diversity in possible observed interactions. Nanomaterials were tested at the relatively low concentrations of 0.5, 0.1 and 0.05 mg/mL, since the concentrations of nanoparticles in the environment are unlikely to reach higher values [52]. A number of experiments were performed to determine: nanoparticle zeta potentials, phage plaque-forming ability after coincubation with nanoparticles and phage lytic performance in the presence of nanoparticles. Phage progeny boost times and titers were also determined by the eclipse phase determinations along with TEM micrographs of the interactions. Microscopic analysis of the tested samples showcased phage–nanoparticle physical attachments (Table 2).
In this study, nanoparticle zeta potential (ZP) values along with electron microscopy images were crucial to explain the rest of the results. Since the overall ZP value for T4 phage is close to neutral (−1.1 ± 0.49 mV) [53], the results were interpreted based on the distribution of phage charges (negatively charged phage head and positively charged tail) [54].
Our results are interpreted with caution; however, it can be hypothesized that the mere presence of the nanoparticle charge, negative or positive, is not enough for the phage to attach specifically to the particle and consequently influence the phage performance. The zeta potential value of the nanoparticle is of the greatest influence—particles with a ZP lower than −35 [mV] bind effectively with positively charged phage tails, whereas particles with a ZP higher than 35 [mV] bind effectively with negatively charged phage heads (Figure 6). This was also additionally proven for CNT-TiO2 particles (Supplementary Material, Figure S5). When the particles do not meet these requirements, phage–nanoparticle physical interaction becomes nonspecific (Table 2).
These are in agreement with previous studies, where Cademartiri et al. [55] reported that tailed Myoviridae and Siphoviridae phages will effectively physisorb to porous silica spheres, rendered cationic or anionic by surface modification. Phage did not adsorb effectively to surfaces modified with neutral groups, and the number of infective phages bound to the silica was enhanced by the presence of ionic surfaces, with a greater surface charge correlating with greater concentration of adsorbed phages. The electrostatic attachment was also tested by Richter et al. [51], who engineered gold nanoparticles coated with a mixture of negatively charged 11-mercapto 1-undecanesulfonic acid (MUS) and hydrophobic 1-octanethiol (OT), which deactivated various types of Escherichia coli-selective phages: T1, T4 and T7. Moreover, the importance of the electrostatic forces was confirmed, since non-charged nanoparticles showed no effect in all analyzed cases. Thus, it was confirmed that the interactions between phages and nanoparticles can be predicted on the basis of the electrostatic forces between the averaged charges of phage proteins (represented by their pI) and the charges of nanoparticles [51]. We observed decreased phage lytic performance in the combination with SiO2 (ZP = −51 ± 0.3 [mV]) and Fe3O4-SiO2 (ZP = −37.6 ± 0.6 [mV]), which, as proposed by Khan et al. [56], is caused by the tail fiber target binding of the T4 phage; hence, the adsorption of the tail to a substrate (here, nanoparticles) limits the ability of T4 to bind targets (bacteria).
Tested nanoparticle concentrations had a minor influence on the phage–nanoparticle interactions, except for phage plaque-forming ability after coincubation with nanomaterials, and, only a slight influence on phage progeny boost time during the eclipse phase (±2 min) (Table 2). After coincubation, the phage was removed from the nanoparticle environment and, hence, the acquired phages could be the ones that: did not attach to the particles (small nanoparticles concentration/low availability), were left in the particle sediment after attachment, detached due to the small ZP value (t = 60 min) or did not have enough time to attach (t = 0 min). Moreover, it has been shown that even if the nanoparticles have a negative effect on phage lysis, when phage detaches, no permanent structural changes are incurred that produce inhibitory effects on infection after nanoparticles are removed [57]. Similarly, Khan et al. [56] noted that, contrary to predictions based on the charge differential for T4, the retention of activity was seen not only for phages adsorbed to cationic particles, but also for those bound to anionic spheres.
Similar to the present work, Gilcrease et al. [57] also tested whether bacteriophage lytic growth cycle is affected by the presence of nanoparticles, using silver nanoparticles with coating materials. One-step growth curves of bacteriophages showed that the presence of these nanoparticles resulted in 96% reductions in phages PFUs. However, when tailed Siphoviridae and Myoviridae phages were exposed to silver nanoparticles coated with poly-N-vinyl-2 pyrrolidone (PVP), final phage yield increased by 250%, compared with the same phage not incubated with nanoparticles. However, researchers suggest that this phenomenon is due to the coating itself, but the mechanism of phage stimulation by PVP was not revealed. In our results, we observed the cases of phage and negatively charged nanoparticles, in which eclipse periods showed quick phage progeny boost and titer, with a simultaneous decrease in phage lytic activity and phage tail binding (SiO2 and Fe3O4-SiO2). It can be hypothesized that after the first phage progeny burst, the phage particles are gradually captured over time by the negatively charged nanoparticles; hence, with each infective cycle, the amount of phage available to the bacteria decreases. In the cases where we noted increased lytic activity of the phage along with head binding to the positively charged nanoparticles (TiO2) or nonspecific phage binding (SiO2-TiO2, Fe3O4 and Fe3O4-SiO2-TiO2), it can be hypothesized that phage T45 and nanoparticles worked in synergy. Similarly, You et al. [9] observed that 1 h prior exposure to silver and zinc oxide nanoparticles did not inactivate the MS2 phage at the highest nanoparticle concentrations tested (5 mg/L total Ag and 20 mg/L ZnO), but in a complex system where the E. coli was exposed to MS2 and nanoparticles simultaneously, the number of phages increased by 2–6 orders of magnitude.
A single T4-like phage virion is a colloidal particle, often having a dipole moment [7]. Therefore, it can be successfully bound to various nanomaterials with an appropriate (measurable) electric charge and increase or decrease the antimicrobial activity in the phage. For this reason, phages can be used not only in effective phage therapy, but also in biocontrol applications, e.g., in the food industry and agriculture, to protect dairy products, fruits, vegetables, meat and fish [7]. It should be noted, however, that the development of future disinfection solutions based on bacteriophages and nanoparticles may be hampered by the instability of phage and nanoparticle physical attachments, which could potentially be solved by the use of nanoparticles with, preferably, high zeta potentials.

5. Conclusions

In this paper, the interactions of six different nanoparticles and T4-like phages were revealed. Decreased phage lytic performance in the presence of nanoparticles having a ZP < −35 [mV] was observed. Particles with a low ZP cause the phage to attach with its tail fibers; hence, the adsorption of the phage tail to nanoparticle limits the ability of the phage to bind targets (bacteria). However, in some cases, retention of phage activity (plaque-forming ability) has been shown when the phage detached from the nanoparticle and was removed from the nanoparticle environment. No permanent changes were incurred that produced inhibitory effects on later phage infection. Increased phage lytic activity in the presence of nanoparticles was also noted. This was the case when the phage attached to the positively charged nanoparticles by the head, and when nonspecific phage binding took place, which could indicate antibacterial phage–nanoparticle synergy. However, generally, our results concerning nano–phage–bacteria mixtures are interpreted with caution, due to the probability of occurrence of some additional bacteria–nanoparticle interactions.
Overall, it was established that the mere presence of the nanoparticle charge is not sufficient for specific phage binding to a nanoparticle. The greatest influence in phage–nanoparticle interactions is the zeta potential (ZP) value of the nanoparticle. It was demonstrated that particles with a ZP lower than −35 (mV) bind effectively with positively charged phage tails, and particles with a ZP higher than 35 (mV) bind effectively with negatively charged phage heads. Particles which do not meet these requirements cause phage–nanoparticle physical interaction to become nonspecific. In consequence, interactions between phages and nanoparticles can be predicted on the basis of the particle charges expressed in ZP values.

Supplementary Materials

The following supporting information can be downloaded at: www.mdpi.com/article/10.3390/ijms23137179/s1.

Author Contributions

Conceptualization, X.S., K.C. and P.N.; methodology, X.S., K.C. and P.N.; validation, X.S., K.C. and P.N.; formal analysis, X.S.; investigation, X.S., K.C. and A.P.; resources, X.S., K.C., K.P, A.P., E.M. and P.N.; data curation, X.S., K.C. and A.P.; writing—original draft preparation, X.S., K.C. and P.N.; writing—review and editing, X.S., K.C., K.P., A.P., E.M. and P.N.; visualization, X.S. and K.C.; supervision, E.M. and P.N.; project administration, K.P.; funding acquisition, K.P. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Science Centre, Poland, within the PRELUDIUM Program, grant number 2017/25/N/ST5/01222.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Sunderland, K.S.; Yang, M.; Mao, C. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine. Angew. Chem. Int. Ed. 2017, 56, 1964–1992. [Google Scholar] [CrossRef] [Green Version]
  2. Abedon, S.T.; García, P.; Mullany, P.; Aminov, R. Editorial: Phage Therapy: Past, Present and Future. Front. Microbiol. 2017, 8, 981. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Stachurska, X.; Roszak, M.; Jabłońska, J.; Mizielińska, M.; Nawrotek, P. Double-Layer Agar (DLA) Modifications for the First Step of the Phage-Antibiotic Synergy (PAS) Identification. Antibiotics 2021, 10, 1306. [Google Scholar] [CrossRef] [PubMed]
  4. Chan, B.K.; Abedon, S.T.; Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013, 8, 769–783. [Google Scholar] [CrossRef] [PubMed]
  5. Hatfull, G.F. Bacteriophage genomics. Curr. Opin. Microbiol. 2008, 5, 447–453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Hendrix, R.W.; Hatfull, G.F.; Smith, M.C. Bacteriophages with tails: Chasing their origins and evolution. Res. Microbiol. 2003, 154, 253–257. [Google Scholar] [CrossRef]
  7. Paczesny, J.; Bielec, K. Application of Bacteriophages in Nanotechnology. Nanomaterials 2020, 10, 1944. [Google Scholar] [CrossRef]
  8. Nawrotek, P.; Stachurska, X.; Augustyniak, A. Perspektywiczne możliwości wykorzystania kombinacji działania bakteriofagów i nanomateriałów w zwalczaniu chorób bakteryjnych u zwierząt. Med. Weter. 2020, 76, 375–381. [Google Scholar] [CrossRef]
  9. You, J.; Zhang, Y.; Hu, Z. Bacteria and bacteriophage inactivation by silver and zinc oxide nanoparticles. Colloids Surf. B Biointerfaces 2011, 85, 161–167. [Google Scholar] [CrossRef]
  10. Stark, W.J. Nanoparticles in Biological Systems. Angew. Chem. Int. Ed. 2011, 50, 1242–1258. [Google Scholar] [CrossRef]
  11. Petros, R.A.; DeSimone, J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9, 615–627. [Google Scholar] [CrossRef] [PubMed]
  12. Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of Nanoparticles. Small 2008, 4, 26–49. [Google Scholar] [CrossRef] [PubMed]
  13. Ravishankar, R.V.; Jamuna, B.A. Nanoparticles and their potential application as antimicrobials. In Science against Microbial Pathogens: Communicating Current Research and Technological Advances; Méndez-Vilas, A., Ed.; Microbiology Series No. 3; Formatex: Badajoz, Spain, 2011; Volume 1, p. 197. [Google Scholar]
  14. Dizaj, S.M.; Lotfipour, F.; Barzegar-Jalali, M.; Zarrintan, M.H.; Adibkia, K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater. Sci. Eng. C 2014, 44, 278–284. [Google Scholar] [CrossRef]
  15. Salata, O.C. Applications of nanoparticles in biology and medicine. J. Nanobiotechnology 2004, 2, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Khan, I.; Saeed, K.; Khan, I. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019, 12, 908–931. [Google Scholar] [CrossRef]
  17. Khan, R.H.; Ahmad, E.; Zaman, M.; Qadeer, A.; Rabbani, G. Nanoparticles in relation to peptide and protein aggregation. Int. J. Nanomed. 2014, 9, 899–912. [Google Scholar] [CrossRef] [Green Version]
  18. Hajipour, M.J.; Fromm, K.M.; Ashkarran, A.A.; de Aberasturi, D.J.; de Larramendi, I.R.; Rojo, T.; Serpooshan, V.; Parak, W.J.; Mahmoudi, M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012, 30, 499–511. [Google Scholar] [CrossRef] [Green Version]
  19. Moritz, M.; Geszke-Moritz, M. The newest achievements in synthesis, immobilization and practical applications of antibacterial nanoparticles. Chem. Eng. J. 2013, 228, 596–613. [Google Scholar] [CrossRef]
  20. Zhao, Y.; Chen, Z.; Chen, Y.; Xu, J.; Li, J.; Jiang, X. Synergy of Non-antibiotic Drugs and Pyrimidinethiol on Gold Nanoparticles against Superbugs. J. Am. Chem. Soc. 2013, 135, 12940–12943. [Google Scholar] [CrossRef]
  21. Comeau, A.M.; Tétart, F.; Trojet, S.N.; Prère, M.-F.; Krisch, H.M. Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth. PLoS ONE 2007, 2, e799. [Google Scholar] [CrossRef] [Green Version]
  22. Karimi, M.; Mirshekari, H.; Basri, S.M.M.; Bahrami, S.; Moghoofei, M.; Hamblin, M.R. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos. Adv. Drug Deliv. Rev. 2016, 106, 45–62. [Google Scholar] [CrossRef] [Green Version]
  23. Scibilia, S.; Lentini, G.; Fazio, E.; Franco, D.; Neri, F.; Mezzasalma, A.M.; Guglielmino, S.P.P. Self-assembly of silver nanoparticles and bacteriophage. Sens. Bio-Sens. Res. 2016, 7, 146–152. [Google Scholar] [CrossRef] [Green Version]
  24. Kaikabo, A.A.; Mohammed, A.S.; Abas, F. Chitosan Nanoparticles as Carriers for the Delivery of ΦKAZ14 Bacteriophage for Oral Biological Control of Colibacillosis in Chickens. Molecules 2016, 21, 256. [Google Scholar] [CrossRef]
  25. Li, L.-L.; Yu, P.; Wang, X.; Yu, S.-S.; Mathieu, J.; Yu, H.-Q.; Alvarez, P.J.J. Enhanced biofilm penetration for microbial control by polyvalent phages conjugated with magnetic colloidal nanoparticle clusters (CNCs). Environ. Sci. Nano 2017, 4, 1817–1826. [Google Scholar] [CrossRef]
  26. Segall, A.M.; Roach, D.R.; Strathdee, S.A. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Curr. Opin. Microbiol. 2019, 51, 46–50. [Google Scholar] [CrossRef]
  27. Tagliaferri, T.L.; Jansen, M.; Horz, H.-P. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Front. Cell. Infect. Microbiol. 2019, 9, 22. [Google Scholar] [CrossRef]
  28. Akturk, E.; Oliveira, H.; Santos, S.B.; Costa, S.; Kuyumcu, S.; Melo, L.D.R.; Azeredo, J. Synergistic Action of Phage and Antibiotics: Parameters to Enhance the Killing Efficacy against Mono and Dual-Species Biofilms. Antibiotics 2019, 8, 103. [Google Scholar] [CrossRef] [Green Version]
  29. Mangalea, M.R.; Duerkop, B.A. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies. Infect. Immun. 2020, 88, e00926-19. [Google Scholar] [CrossRef] [Green Version]
  30. Zhang, Q.-G.; Buckling, A. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. Evol. Appl. 2012, 5, 575–582. [Google Scholar] [CrossRef]
  31. Dickey, J.; Perrot, V. Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro. PLoS ONE 2019, 14, e0209390. [Google Scholar] [CrossRef] [Green Version]
  32. Jo, A.; Kim, J.; Ding, T.; Ahn, J. Role of phage-antibiotic combination in reducing antibiotic resistance in Staphylococcus aureus. Food Sci. Biotechnol. 2016, 25, 1211–1215. [Google Scholar] [CrossRef]
  33. Oechslin, F.; Piccardi, P.; Mancini, S.; Gabard, J.; Moreillon, P.; Entenza, J.M.; Resch, G.; Que, Y.-A. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J. Infect. Dis. 2017, 215, 703–712. [Google Scholar] [CrossRef] [Green Version]
  34. Hosseinidoust, Z.; Olsson, A.L.; Tufenkji, N. Going viral: Designing bioactive surfaces with bacteriophage. Colloids Surf. B 2014, 124, 2–16. [Google Scholar] [CrossRef]
  35. Appleyard, R.K. Segregation of new lysogenic types during growth of a doubly lysogenic strain derived from Escherichia coli K12. Genetics 1954, 39, 440–452. [Google Scholar] [CrossRef]
  36. Kropinski, A.M.; Mazzocco, A.; Waddell, T.E.; Lingohr, E.; Johnson, R.P. Enumeration of bacteriophages by double agar overlayplaque assay. In Bacteriophages. Methods in Molecular Biology; Clokie, M.R., Kropinski, A.M., Eds.; Humana Press: Totowa, NJ, USA, 2009; Volume 501, pp. 69–76. [Google Scholar]
  37. Cendrowski, K.; Sikora, P.; Zielinska, B.; Horszczaruk, E.; Mijowska, E. Chemical and thermal stability of core-shelled magnetite nanoparticles and solid silica. Appl. Surf. Sci. 2017, 407, 391–397. [Google Scholar] [CrossRef]
  38. Cendrowski, K. Titania/mesoporous silica nanotubes with efficient photocatalytic properties. Pol. J. Chem. Technol. 2018, 20, 103–108. [Google Scholar] [CrossRef] [Green Version]
  39. Augustyniak, A.; Cendrowski, K.; Nawrotek, P.; Barylak, M.; Mijowska, E. Investigating the Interaction between Streptomyces sp. and Titania/Silica Nanospheres. Water, Air, Soil Pollut. 2016, 227, 230. [Google Scholar] [CrossRef]
  40. Cendrowski, K.; Chen, X.; Zielinska, B.; Kalenczuk, R.J.; Rümmeli, M.H.; Büchner, B.; Klingeler, R.; Borowiak-Palen, E. Synthesis, characterization, and photocatalytic properties of core/shell mesoporous silica nanospheres supporting nanocrystalline titania. J. Nanoparticle Res. 2011, 13, 5899–5908. [Google Scholar] [CrossRef]
  41. Cendrowski, K.; Kukułka, W.; Wierzbicka, J.; Mijowska, E. The river water influence on cationic and anionic dyes collection by nickel foam with carbonized metal-organic frameworks and carbon nanotubes. J. Alloy. Compd. 2021, 876, 160093. [Google Scholar] [CrossRef]
  42. Cendrowski, K.; Peruzynska, M.; Markowska-Szczupak, A.; Chen, X.; Wajda, A.; Lapczuk, J.; Kurzawski, M.; Kalenczuk, R.J.; Drozdzik, M.; Mijowska, E. Mesoporous Silica Nanospheres Functionalized by TiO2 as a Photoactive Antibacterial Agent. J. Nanomed. Nanotechnol. 2013, 4, 182. [Google Scholar] [CrossRef] [Green Version]
  43. Ackermann, H.W. Phage classification and characterization. In Bacteriophages. Methods in Molecular Biology; Clokie, M.R., Kropinski, A.M., Eds.; Humana Press: Totowa, NJ, USA, 2009; Volume 501, pp. 127–140. [Google Scholar]
  44. Cao, B.; Xu, H.; Mao, C. Transmission electron microscopy as a tool to image bioinorganic nanohybrids: The case of phage-gold nanocomposites. Microsc. Res. Tech. 2011, 74, 627–635. [Google Scholar] [CrossRef] [Green Version]
  45. Merzlyak, A.; Lee, S.-W. Phage as templates for hybrid materials and mediators for nanomaterial synthesis. Curr. Opin. Chem. Biol. 2006, 10, 246–252. [Google Scholar] [CrossRef]
  46. You, F.; Yin, G.; Pu, X.; Li, Y.; Hu, Y.; Huang, Z.; Liao, X.; Yao, Y.; Chen, X. Biopanning and characterization of peptides with Fe3O4 nanoparticles-binding capability via phage display random peptide library technique. Colloids Surf. B 2016, 141, 537–545. [Google Scholar] [CrossRef]
  47. Peng, H.; Chen, I.A. Rapid Colorimetric Detection of Bacterial Species through the Capture of Gold Nanoparticles by Chimeric Phages. ACS Nano 2018, 13, 1244–1252. [Google Scholar] [CrossRef]
  48. Souza, G.R.; Christianson, D.R.; Staquicini, F.I.; Ozawa, M.G.; Snyder, E.Y.; Sidman, R.L.; Miller, J.H.; Arap, W.; Pasqualini, R. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc. Natl. Acad. Sci. USA 2006, 103, 1215–1220. [Google Scholar] [CrossRef] [Green Version]
  49. Handa, H.; Gurczynski, S.; Jackson, M.P.; Auner, G.; Walker, J.; Mao, G. Recognition of Salmonella typhimurium by immobilized phage P22 monolayers. Surf. Sci. 2008, 602, 1392–1400. [Google Scholar] [CrossRef] [Green Version]
  50. Balasubramanian, S.; Sorokulova, I.B.; Vodyanoy, V.J.; Simonian, A.L. Lytic phage as a specific and selective probe for detection of Staphylococcus aureus—A surface plasmon resonance spectroscopic study. Biosens. Bioelectron. 2007, 22, 948–955. [Google Scholar] [CrossRef]
  51. Richter, L.; Paszkowska, K.; Cendrowska, U.; Olgiati, F.; Silva, P.J.; Gasbarri, M.; Guven, Z.P.; Paczesny, J.; Stellacci, F. Broad-spectrum nanoparticles against bacteriophage infections. Nanoscale 2021, 13, 18684–18694. [Google Scholar] [CrossRef]
  52. Gottschalk, F.; Sun, T.; Nowack, B. Environmental concentrations of engineered nanomaterials: Review of modeling and analytical studies. Environ. Pollut. 2013, 181, 287–300. [Google Scholar] [CrossRef]
  53. Grygorcewicz, B.; Rakoczy, R.; Roszak, M.; Konopacki, M.; Kordas, M.; Piegat, A.; Serwin, N.; Cecerska-Heryć, E.; El Fray, M.; Dołęgowska, B. Rotating Magnetic Field-Assisted Reactor Enhances Mechanisms of Phage Adsorption on Bacterial Cell Surface. Curr. Issues Mol. Biol. 2022, 44, 1316–1325. [Google Scholar] [CrossRef]
  54. Anany, H.; Chen, W.; Pelton, R.; Griffiths, M.W. Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in Meat by Using Phages Immobilized on Modified Cellulose Membranes. Appl. Environ. Microbiol. 2011, 77, 6379–6387. [Google Scholar] [CrossRef] [Green Version]
  55. Cademartiri, R.; Anany, H.; Gross, I.; Bhayania, R.; Griffiths, M.; Brook, M.A. Immobilization of bacteriophages on modified silica particles. Biomaterials 2010, 31, 1904–1910. [Google Scholar] [CrossRef]
  56. Khan, M.F.; Dong, H.; Chen, Y.; Brook, M.A. Low Discrimination of Charged Silica Particles at T4 Phage Surfaces. Biosens. J. 2015, 4, 125. [Google Scholar] [CrossRef] [Green Version]
  57. Gilcrease, E.; Williams, R.; Goel, R. Evaluating the effect of silver nanoparticles on bacteriophage lytic infection cycle-a mechanistic understanding. Water Res. 2020, 181, 115900. [Google Scholar] [CrossRef]
Ijms 23 07179 g001 550
Figure 1. TEM images of titanium dioxide (A,A’); mesoporous silica spheres (B,B’); mesoporous silica spheres modified with titanium dioxide (C,C’); iron oxide particles (D,D’); covered with mesoporous silica shell before (E,E’) and after functionalization with titanium dioxide (F,F’).
Figure 1. TEM images of titanium dioxide (A,A’); mesoporous silica spheres (B,B’); mesoporous silica spheres modified with titanium dioxide (C,C’); iron oxide particles (D,D’); covered with mesoporous silica shell before (E,E’) and after functionalization with titanium dioxide (F,F’).
Ijms 23 07179 g001
Ijms 23 07179 g002 550
Figure 2. Phage plaque-forming ability after coincubation with selected nanoparticles.
Figure 2. Phage plaque-forming ability after coincubation with selected nanoparticles.
Ijms 23 07179 g002
Ijms 23 07179 g003 550
Figure 3. Area under the curve analysis of phage T45 infection in the presence of nanoparticles at different concentrations (0.5, 0.1 and 0.05 mg/mL), at 180, 210 and 240 min of infection, as derived from lysis profile experiments equivalent to those presented in Supplementary Material (Figure S3). The smaller the area under a lysis profile curve, the greater the reductions in culture turbidity over time—better phage lysis performance. Percent above the dashed lines indicate higher optical density (OD) drops/greater reductions in culture turbidity compared to the control/better phage lysis. Percent below the dashed lines indicate lower OD drops/smaller reductions in culture turbidity compared to the control/weaker phage lysis. Error bars represent standard deviation between samples. Means sharing the star asterisk are significantly different from each other at p ≤ 0.05.
Figure 3. Area under the curve analysis of phage T45 infection in the presence of nanoparticles at different concentrations (0.5, 0.1 and 0.05 mg/mL), at 180, 210 and 240 min of infection, as derived from lysis profile experiments equivalent to those presented in Supplementary Material (Figure S3). The smaller the area under a lysis profile curve, the greater the reductions in culture turbidity over time—better phage lysis performance. Percent above the dashed lines indicate higher optical density (OD) drops/greater reductions in culture turbidity compared to the control/better phage lysis. Percent below the dashed lines indicate lower OD drops/smaller reductions in culture turbidity compared to the control/weaker phage lysis. Error bars represent standard deviation between samples. Means sharing the star asterisk are significantly different from each other at p ≤ 0.05.
Ijms 23 07179 g003
Ijms 23 07179 g004 550
Figure 4. Bacteriophage T45 eclipse periods in the presence of selected nanoparticles At concentrations of 0.5 mg/mL, 0.1 mg/mL and 0.05 mg/mL.
Figure 4. Bacteriophage T45 eclipse periods in the presence of selected nanoparticles At concentrations of 0.5 mg/mL, 0.1 mg/mL and 0.05 mg/mL.
Ijms 23 07179 g004
Ijms 23 07179 g005 550
Figure 5. TEM micrographs of bacteriophage T45 (a,a’) and of phage–nanoparticle interactions (b–g). Red arrows point to the phage particles. SiO2 and phage (b,b’), TiO2-SiO2 and phage (c,c’), TiO2 and phage (d,d’), Fe3O4 and phage (e,e’), SiO2-Fe3O4-TiO2 and phage (f,f’), Fe3O4-SiO2 and phage (g).
Figure 5. TEM micrographs of bacteriophage T45 (a,a’) and of phage–nanoparticle interactions (b–g). Red arrows point to the phage particles. SiO2 and phage (b,b’), TiO2-SiO2 and phage (c,c’), TiO2 and phage (d,d’), Fe3O4 and phage (e,e’), SiO2-Fe3O4-TiO2 and phage (f,f’), Fe3O4-SiO2 and phage (g).
Ijms 23 07179 g005
Ijms 23 07179 g006 550
Figure 6. Proposed graphic explanation of the phenomenon of the electrostatic attachment of the phage T4-like and the tested nanoparticles. NP—nanoparticle.
Figure 6. Proposed graphic explanation of the phenomenon of the electrostatic attachment of the phage T4-like and the tested nanoparticles. NP—nanoparticle.
Ijms 23 07179 g006
Table
Table 1. Characteristics of the tested nanoparticles.
Table 1. Characteristics of the tested nanoparticles.
Material TypeMaterial AbbreviationZeta Potential [mV]
Silica nanospheresSiO2−51 ± 0.3
Meosporous silica nanospheres completed with titanium dioxideTiO2-SiO2−25 ± 0.4
Titanium dioxideTiO236.5 ± 6
Iron oxide nanocubesFe3O4−1.1 ± 1
Iron oxide nanocubes covered with silica shellFe3O4-SiO2−37.6 ± 0.6
Iron oxide nanocubes covered with mesoporous silica shell completed with titanium dioxideSiO2-Fe3O4-TiO2−19.5 ± 0.2
Table
Table 2. Key concentrated results of the present study, based on all of the obtained results.
Table 2. Key concentrated results of the present study, based on all of the obtained results.
NanomaterialConcentration [mg/mL]Zeta Potential [mV]Phage Plaque-Forming Ability at t = 0 hPhage Plaque-Forming Ability at t = 60 hPhage Lytic Performance after 240 minPhage Progeny Boost TimePhage Progeny Titer [PFU/mL]Phage Attachment
SiO20.5−51 ± 0.3Visibly reducedVisibly reducedDecreasedFrom 12 min2.22 × 107Tail
0.1PartialPartialDecreasedFrom 12 min2.84 × 107
0.05PartialFullDecreasedFrom 12 min2.52 × 107
SiO2-TiO20.5−25 ± 0.4FullVisibly reducedIncreasedFrom 10 min2.06 × 107Nonspecific
0.1FullPartialIncreasedFrom 10 min1.99 × 107
0.05FullFullIncreasedFrom 12 min2.06 × 107
TiO20.536.5 ± 6FullFullIncreasedFrom 12 min1.59 × 107Head
0.1PartialFullIncreasedFrom 12 min2.29 × 107
0.05Visibly reducedPartialIncreasedFrom 12 min2.1 × 107
Fe3O40.5−1.1 ± 1PartialFullIncreasedFrom 12 min1.7 × 107Nonspecific
0.1PartialFullIncreasedFrom 12 min9.22 × 106
0.05PartialFullIncreasedFrom 14 min1.94 × 107
Fe3O4-SiO20.5−37.6 ± 0.6PartialFullDecreasedFrom 10 min2.79 × 107Tail
0.1PartialFullDecreasedAfter 16 min2.76 × 106
0.05PartialFullDecreasedFrom 10 min3.37 × 107
Fe3O4-SiO2-TiO20.5−19.5 ± 0.2PartialFullIncreasedFrom 10 min1.91 × 107Nonspecific
0.1FullFullIncreasedFrom 12 min1.24 × 107
0.05FullFullIncreasedFrom 12 min1.86 × 107
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Stachurska, X.; Cendrowski, K.; Pachnowska, K.; Piegat, A.; Mijowska, E.; Nawrotek, P. Nanoparticles Influence Lytic Phage T4-like Performance In Vitro. Int. J. Mol. Sci. 2022, 23, 7179. https://doi.org/10.3390/ijms23137179

AMA Style

Stachurska X, Cendrowski K, Pachnowska K, Piegat A, Mijowska E, Nawrotek P. Nanoparticles Influence Lytic Phage T4-like Performance In Vitro. International Journal of Molecular Sciences. 2022; 23(13):7179. https://doi.org/10.3390/ijms23137179

Chicago/Turabian Style

Stachurska, Xymena, Krzysztof Cendrowski, Kamila Pachnowska, Agnieszka Piegat, Ewa Mijowska, and Paweł Nawrotek. 2022. "Nanoparticles Influence Lytic Phage T4-like Performance In Vitro" International Journal of Molecular Sciences 23, no. 13: 7179. https://doi.org/10.3390/ijms23137179

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop